Trial intelligence / Profile preview

Oral midazolam solution for sedation in pediatric patients before examinations, surgery or treatment (single-arm, multicenter, phase IV)

ChiCTR2300076185Phase 4Recruiting

Sponsor
Third Xiangya Hospital, Central South University
Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of midazolam in None and preoperative anxiety, sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Ramsay sedation score. Started Sep 2023; status: recruiting.

02

Drugs

midazolam
03

Conditions

preoperative anxiety

Beyond the preview

Go deeper on ChiCTR2300076185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300076185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call